Crescita Therapeutics Inc (CTX) - Total Liabilities

Latest as of December 2025: CA$4.75 Million CAD ≈ $3.44 Million USD

Based on the latest financial reports, Crescita Therapeutics Inc (CTX) has total liabilities worth CA$4.75 Million CAD (≈ $3.44 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Crescita Therapeutics Inc net asset momentum to track the company's year-over-year net asset growth rate.

Crescita Therapeutics Inc - Total Liabilities Trend (2014–2025)

This chart illustrates how Crescita Therapeutics Inc's total liabilities have evolved over time, based on quarterly financial data. See CTX free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.

Crescita Therapeutics Inc Competitors by Total Liabilities

The table below lists competitors of Crescita Therapeutics Inc ranked by their total liabilities.

Company	Country	Total Liabilities
ISCC FINTECH SPA F:L7H	Germany	€5.75 Million
Nico Resources Ltd AU:NC1	Australia	AU$434.09K
Nuvotec KQ:060260	Korea	₩32.17 Billion
Perfect Moment Ltd. NYSE MKT:PMNT	USA	$12.74 Million
Canaf Investments Inc V:CAF	Canada	CA$2.23 Million
Revenue Group Bhd KLSE:0200	Malaysia	RM92.63 Million
K-Tig Ltd AU:KTG	Australia	AU$4.49 Million
Binasat Communications Bhd KLSE:0195	Malaysia	RM58.05 Million

Liability Composition Analysis (2014–2025)

This chart breaks down Crescita Therapeutics Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see CTX market cap.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	3.33	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.31	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.23	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Crescita Therapeutics Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Crescita Therapeutics Inc (2014–2025)

The table below shows the annual total liabilities of Crescita Therapeutics Inc from 2014 to 2025.

Year	Total Liabilities	Change
2025-12-31	CA$4.75 Million ≈ $3.44 Million	-20.09%
2024-12-31	CA$5.95 Million ≈ $4.30 Million	+2.96%
2023-12-31	CA$5.78 Million ≈ $4.18 Million	-21.82%
2022-12-31	CA$7.39 Million ≈ $5.34 Million	-12.02%
2021-12-31	CA$8.40 Million ≈ $6.07 Million	+47.37%
2020-12-31	CA$5.70 Million ≈ $4.12 Million	-0.54%
2019-12-31	CA$5.73 Million ≈ $4.14 Million	-33.06%
2018-12-31	CA$8.56 Million ≈ $6.19 Million	-9.52%
2017-12-31	CA$9.46 Million ≈ $6.84 Million	-41.65%
2016-12-31	CA$16.21 Million ≈ $11.73 Million	+255.95%
2015-12-31	CA$4.55 Million ≈ $3.29 Million	+21.86%
2014-12-31	CA$3.74 Million ≈ $2.70 Million	--

About Crescita Therapeutics Inc

TO:CTX Canada Drug Manufacturers - Specialty & Generic

Market Cap

$10.64 Million

CA$14.71 Million CAD

Market Cap Rank

#26871 Global

#1104 in Canada

Share Price

CA$0.79

Change (1 day)

+0.00%

52-Week Range

CA$0.42 - CA$0.79

All Time High

CA$1.82